GRI
GRI
NASDAQ · Biotechnology

Gri Bio Inc

$1.74
-0.08 (-4.40%)
Analyst Consensus
Strong Buy
6
Analysts
Moderate
Coverage
Buy 5 83%
Hold 1 17%
Sell 0 0%
Price Target
Analyst Price Target +2,163.8% upside
Low Target $26.66
Average Target $39.39
High Target $54.88
Current Price $1.74
Current
$1.74
Target
$39.39
$26.66 $39.39 avg $54.88
Scenario Analysis
Bear Case
$26.66
1,432.2%
Low target
Base Case
$39.39
+2,163.8%
Avg target
Bull Case
$54.88
+3,054.0%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$64.12
-97.3% from high
52-Week Low
$1.36
+27.9% from low
Target vs 52W High
$39.39
-38.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.5%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%